Patents by Inventor William A. Ernst

William A. Ernst has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20140287022
    Abstract: The present invention relates to liposomal vaccine compositions, methods for the manufacture thereof, and methods for the use thereof to stimulate an immune response in an animal. These compositions comprise liposomes formed from dimyristoylphosphatidylcholine (“DMPC”); either dimyristoylphosphatidylglycerol (“DMPG”) or dimyristoyltrimethylammonium propane (“DMTAP”) or both DMPC and DMTAP; and at least one sterol; and an antigenic polypeptide comprising a first polypeptide sequence, and a second polypeptide sequence heterologous the first polypeptide sequence which comprises a transmembrane sequence from a membrane protein, said transmembrane sequence having a number of residues sufficient to cross a lipid bilayer, at least nine contiguous residues of which are predicted to form an alpha helix having a hydrophobicity score of about 0.7 or greater.
    Type: Application
    Filed: April 25, 2012
    Publication date: September 25, 2014
    Applicant: MOLECULAR EXPRESS, INC.
    Inventors: Gary Fujii, William A. Ernst, Jill Adler-Moore, Linda Vician
  • Patent number: 5688525
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: June 30, 1993
    Date of Patent: November 18, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Jill P. Adler-Moore, William A. Ernst
  • Patent number: 5670166
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: September 23, 1997
    Assignee: NeXstar Pharmaceuticals
    Inventors: Jill P. Adler-Moore, William A. Ernst
  • Patent number: 5660856
    Abstract: A process for preparing a liposomal cyclosporin therapeutic formulation, which comprises dissolving a combination of a neutral and negatively charged phospholipid and a cyclosporin in an organic solvent; drying the solution to form a solid phase, and hydrating the solid phase in an aqueous solution having a pH ranging from 7.5 to 9.5.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: August 26, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Jill P. Adler-Moore, William A. Ernst
  • Patent number: 4466607
    Abstract: A device for inverting a sheet includes an input and output transport means and a sheet receiving tray. Sheet deflectors are provided to deflect portions of a sheet as it leaves the input transport means and moves into the tray. A reversal drive arrangement, including a drive roller within a vacuum plenum, contacts a sheet supplied to the tray and moves the sheet into engagement with the sheet output transport means. This arrangement adds beam strength to a sheet entering the tray and permits a second sheet to be supplied to the tray prior to complete removal of the previously inverted sheet.
    Type: Grant
    Filed: March 8, 1982
    Date of Patent: August 21, 1984
    Assignee: The Mead Corporation
    Inventors: Albert R. Clark, William A. Ernst, Svetislav Mitrovich, James E. Self